EPICS: Global Perspectives in SCLC (Region 1) 2022
Latest therapeutic developments in SCLC treatment and implications on individualized clinical decision-making. How will emerging data shape future treatment paradigms?
June 29, 2022
FACULTY CHAIR
Carl M. Gay, MD, PhD
MD Anderson Cancer Center, Houston, TX, USA
Faculty Members
Apar Kishor Ganti, MD
University of Nebraska Medical Center, Omaha, NE, USA
Jyoti Malhotra, MD, MPH
City of Hope, Duarte, CA, USA
Alberto Chiappori, MD
Moffitt Cancer Center, Tampa, FL, USA
Nagla Abdel Karim, MD
Augusta University, St, Augusta, GA, USA
Anne Chiang, MD, PhD
Yale School of Medicine, New Haven, CT, USA
Joshua K. Sabari, MD
NYU Grossman School of Medicine, New York, NY, USA
REPORT TOPICS INCLUDE
- Standards of Care Across the SCLC Treatment Continuum
- Biomarkers in SCLC
- Recent Progress and Emerging Therapies in Second Line and Beyond
